Yale University

Researchers at Yale University found that patients can obtain GLP-1 prescriptions from online platforms in as little as five minutes using fake profiles, raising significant concerns about the level of clinical oversight in direct-to-consumer healthcare. A study published July 6 in the JAMA medical journal revealed that 45 out of 49 websites tested issued prescriptions with minimal medical scrutiny, often bypassing video consultations or blood work.

How Easily Can GLP-1s Be Obtained Online?

Between August and December 2025, Yale researchers tested 49 websites by creating “simulated patient profiles” that met basic eligibility criteria for GLP-1 medications. The results showed a high success rate for obtaining prescriptions, with only four websites denying the request. According to the study, the median time to receive a prescription was one day or less, and two platforms issued prescriptions for compounded GLP-1s in five minutes or less.

Did you know?
Twenty percent of the websites in the study issued prescriptions based solely on an upper-body photo, despite their own requirements for full-body images or photos showing the patient on a scale.

What Are the Risks of Impersonal Clinical Care?

The study highlights a trend where speed is prioritized over comprehensive patient history. While most websites utilized questionnaires to screen for medical conditions and allergies, only 13 required a video visit, and just three required a phone call. Researchers noted that 75% of the platforms charged and shipped the medications automatically without confirming with the patient first.

Study shows patients who use GLP-1 drugs can weight back faster

“This secret shopper study found that online GLP-1 RA prescription vendors often did not require clinician interaction, relying primarily on patient-reported questionnaires that may not capture important clinical and social history,” the study reported. The researchers identified issues such as multiple prescriptions issued by the same clinicians and a lack of verification for required medical photos.

The Future of Compounded GLP-1 Regulations

A major focus of the study was the prevalence of compounded GLP-1 medications, which were sold by 39 of the 49 websites tested. Researchers observed that these platforms often used “leading” questions regarding personalization to justify the continued sale of compounded versions of the drug.

Federal regulations permit drug compounding only when a medication is in shortage or when a specific patient needs a customized dosage form, such as a liquid rather than a pill. With

July 8, 2026 0 comments

The End of the ‘Low-Fat’ Era: Why the Type of Fat Matters More Than the Amount

For decades, the dietary mantra for cancer prevention was simple: eat less fat. Whether it was the lean-protein craze of the 90s or the modern push for low-calorie diets, the focus remained squarely on quantity. However, groundbreaking research is shifting the narrative, suggesting that when it comes to the pancreas, the kind of fat you consume is far more critical than the total grams on your nutrition label.

Recent findings from Yale School of Medicine indicate that dietary fats aren’t just fuel; they act as biological switches. While some fats may act as a shield for cancer cells, others can effectively trigger their destruction. This discovery opens the door to a new era of precision nutrition, where diet is used as a targeted tool to suppress tumor growth.

Did you know? Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive forms of cancer, with a five-year survival rate of only about 13%. Because treatment options for advanced stages are limited, dietary prevention is becoming a primary focus for oncologists.

The Olive Oil Paradox: Heart-Healthy vs. Tumor-Fueling

One of the most startling revelations in recent oncology research is the role of oleic acid. Found predominantly in olive oil—long hailed as the gold standard for cardiovascular health—oleic acid is a monounsaturated fatty acid (MUFA). While it may keep your arteries clear, it may be playing a dangerous game in the pancreas.

In studies involving mice genetically prone to pancreatic cancer, diets rich in oleic acid (found in olive oil, peanuts and certain sunflower oils) significantly accelerated tumor growth. This creates a complex medical paradox: a fat that protects the heart might inadvertently protect a tumor.

The reason lies in a process called ferroptosis. This represents a form of programmed cell death triggered by lipid oxidation. Essentially, when certain fats oxidize, they create a toxic environment that kills the cancer cell. However, monounsaturated fats like oleic acid are highly resistant to this oxidation. By integrating into the cancer cell’s membrane, they act as a protective armor, preventing the cell from dying and allowing the tumor to thrive.

The Power of Omega-3s: Turning the Tide on Tumor Growth

If MUFAs act as a shield for cancer, polyunsaturated fatty acids (PUFAs)—specifically omega-3s found in fish oil—act as the sword. Unlike the stable structure of oleic acid, omega-3s oxidize easily. When these fats are present in the cell membranes of pancreatic tumors, they make the cells highly vulnerable to ferroptosis.

The data is compelling: researchers observed a 50% reduction in disease burden in mice fed diets enriched with fish oil compared to those on standard fat diets. This suggests that the ratio of MUFAs to PUFAs in our diet could be a decisive factor in whether a dormant mutation evolves into a malignant tumor.

For those looking to optimize their health, this highlights the importance of incorporating fatty fish (like salmon and mackerel) or high-quality algae-based omega-3 supplements, while being mindful of the over-reliance on a single fat source.

Pro Tip: Don’t slash all fats from your diet. Your brain and hormones require lipids to function. Instead, focus on “lipid swapping”—replacing excessive monounsaturated oils with omega-3 rich sources under the guidance of a nutritionist.

Future Trends: Precision Nutrition and Biological Sex

As we look toward the future of cancer prevention, we are moving away from “one size fits all” dietary guidelines. We can expect several key trends to emerge in clinical practice:

View this post on Instagram about Tumor Growth, Future Trends

From Instagram — related to Tumor Growth, Future Trends

1. Biomarker-Driven Dietetics

Imagine a routine blood test that measures the ratio of MUFAs to PUFAs in your phospholipids. In the future, this could serve as an early warning system. Patients with a high MUFA-to-PUFA ratio might be flagged as “high risk” for pancreatic cancer and prescribed a specific dietary intervention to increase their sensitivity to ferroptosis.

2. Gender-Specific Nutritional Protocols

The Yale study uncovered a fascinating biological divide: oleic acid promoted tumor growth primarily in males, while females showed little to no effect. This suggests that metabolic responses to dietary fats are sex-dependent. Future oncology guidelines will likely offer different dietary recommendations for men and women to account for these hormonal and metabolic differences.

3. Adjunct Dietary Therapy

Rather than replacing chemotherapy, dietary fat manipulation may be used as a “primer.” By shifting a patient’s lipid profile toward PUFAs before treatment, doctors may be able to make tumors more susceptible to existing therapies that trigger oxidative stress.

Frequently Asked Questions

Q: Should I stop using olive oil entirely?
A: Not necessarily. These findings are currently based on animal models. Olive oil remains beneficial for heart health. However, for those with a high genetic risk of pancreatic cancer, diversifying fat sources to include more omega-3s is a prudent strategy. Always consult your doctor before making drastic dietary changes.

Q: What is ferroptosis in simple terms?
A: Think of it as “iron-dependent cell suicide.” It happens when the fats in a cell’s membrane rust (oxidize) so much that the cell bursts and dies. This is a great thing when the cell is a cancer cell.

Q: Are all unsaturated fats the same?
A: No. Monounsaturated fats (MUFAs) are more stable and resistant to oxidation, while Polyunsaturated fats (PUFAs) are more reactive. This chemical difference is exactly why they have opposite effects on tumor survival.

For more insights into the intersection of genetics and nutrition, explore our latest guides on metabolic health and preventative oncology. You can also find detailed clinical data via the American Cancer Society or the National Institutes of Health (NIH).

Join the Conversation: Do you prioritize heart-healthy fats in your diet, or have you already made the switch to omega-3 rich foods? Let us know in the comments below or subscribe to our newsletter for the latest breakthroughs in precision medicine!

Online GLP-1 Prescriptions Often Bypass Meaningful Clinician Interaction